• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE LTD FREESTYLE LIBRE 3; CONTINUOUS GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE LTD FREESTYLE LIBRE 3; CONTINUOUS GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 72075-01
Medical Device Problem Codes Device Alarm System (1012); Application Program Problem (2880)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/04/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This complaint was received via user report and has been reported to fda.An extended investigation has been performed for the reported complaint and it has been determined that there was no indication that the product did not meet specification.Software investigation: the customer reported unexpected glucose alarms.After attempting to identify the customer's reported configurations, the information provided in the complaint was insufficient to conduct a comprehensive investigation.The lack of the os version, along with device name and application version, restricts the ability to identify potential causes of the customer's reported issue.The most probable root causes associated with this failure mode are software/data corruption or misuse.However, mitigations are in place to reduce and prevent such issues.All vital functions are monitored by the system and, when necessary, function is suspended to safeguard against inaccurate results.Labeling is provided to instruct the user on the intended use of all vital parts of the system to minimize misuse.All complaints and complaint trends are investigated to determine if there is a product defect/ deficiency.If a product defect/ deficiency is identified, a risk evaluation is completed and compared to the risk management report, to ensure the risk profile has not changed.Additionally, as a part of abbott¿s post-market surveillance process, all risk evaluations with associated complaint data are reviewed annually to determine if the risk profiles have changed as compared to the product risk management reports.These monitoring processes ensure that all product risk profiles remain acceptable and have a positive benefit/ risk ratio.Sensor investigation: a tripped trend review was conducted for the reported complaint and freestyle libre 3 sensors, no trends were identified that would indicate any product related issues.The most probable root causes associated with this failure mode are software/data corruption or misuse.However, mitigations are in place to reduce and prevent such issues.All vital functions are monitored by the system and, when necessary, function is suspended to safeguard against inaccurate results.Labeling is provided to instruct the user on the intended use of all vital parts of the system to minimize misuse.All complaints and complaint trends are investigated to determine if there is a product defect/ deficiency.If a product defect/ deficiency is identified, a risk evaluation is completed and compared to the risk management report, to ensure the risk profile has not changed.Additionally, as a part of abbott¿s post-market surveillance process, all risk evaluations with associated complaint data are reviewed annually to determine if the risk profiles have changed as compared to the product risk management reports.These monitoring processes ensure that all product risk profiles remain acceptable and have a positive benefit/ risk ratio.If the product is returned, a physical investigation will be performed and a follow-up report submitted.All pertinent information available to abbott diabetes care has been submitted.The device manufacturing date does not apply.The date entered in section h4 is the date abbott diabetes care became aware of the event.This is 1 of 3 mdr submission.
 
Event or Problem Description
Abbott diabetes care received a medwatch report which reported the following information pertaining to an abbott diabetes care (adc) device: the customer reported alarm with the adc device in use with unknown phone with android operating system version.It was reported that the customer encountered a "loss of signal" which resulted in the to the device alarming.The customer disabled the audible alarms however, they indicated that the "software overrides all the setting" resulting in a continuous alarm.There was no report of self-treat or third-party medical treatment provided for the reported issue.No contact information was provided to adc, therefore adc is unable to attempt any follow up activities related to this event.Based on the information provided, there was no report of serious injury associated with this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 3
Common Device Name
CONTINUOUS GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
ABBOTT DIABETES CARE LTD
range road
witney 12345 -700
UK  12345-7001
Manufacturer Contact
patricia reis castro
1360 south loop road
alameda 94502-7001
4157205405
MDR Report Key21657880
Report Number2954323-2025-10179
Device Sequence Number8225563
Product Code QLG
UDI-Device Identifier00357599816001
UDI-Public00357599816001
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K213996
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 03/20/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model Number72075-01
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/25/2025
Initial Report FDA Received Date03/20/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/25/2025
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age71 YR
Patient SexMale
Patient Weight80 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-